El Vínculo El Vínculo.
MałopolskieNowosądecki
Closed European Union Supplies

Dostawy produktów leczniczych

Szpital Specjalistyczny im. Jędrzeja Śniadeckiego

Closed. Submission deadline: 12 December 2025. Estimated value: 5,094,706 zł.

Interested in tenders like this? Get the next tenders like this one published in the European Union by email. Free, no card needed.

Amounts and figures

5,094,706 zł
Estimated value
20
Lots

Description

Przedmiot zamówienia obejmuje 20 części: Część nr 1:Interferon β-1a Część nr 2: Glatirameru octan Część nr 3: Fumaran dimetylu Część nr 4: Peginterferon-β-1a Część nr 5: Teryflunomid Część nr 6: Ofatumumab Część nr 7: Ozanimod Część nr 8: Ponesimod Część nr 9: Siponimod Część nr 10: Fingolimod Część nr 11: Natalizumab Część nr 12: Okrelizumab Część nr 13: Kladrybina Część nr 14: Alemtuzumabum Część nr 15: Interferon β- 1a Część nr 16: Interferon β- 1b Część nr 17: Ublituksymab Część nr 18: Immunoglobuliny Część nr 19: Kaplacyzumab Część nr 20: Natalizumab

Lots (20)

LotDescriptionCPV codeAmount
1 Część nr 1:Interferon β-1a
Nowy Sącz, PL218
33650000 General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents —
2 Część nr 2: Glatirameru octan
Nowy Sącz, PL218
33650000 General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents —
3 Część nr 3: Fumaran dimetylu
Nowy Sącz, PL218
33650000 General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents —
4 Część nr 4: Peginterferon-β-1a
Nowy Sącz, PL218
33650000 General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents —
5 Część nr 5: Teryflunomid
Nowy Sącz, PL218
33650000 General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents —
6 Część nr 6: Ofatumumab
Nowy Sącz, PL218
33650000 General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents —
7 Część nr 7: Ozanimod
Nowy Sącz, PL218
33650000 General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents —
8 Część nr 8: Ponesimod
Nowy Sącz, PL218
33650000 General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents —
9 Część nr 9: Siponimod
Nowy Sącz, PL218
33650000 General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents —
10 Część nr 10: Fingolimod
Nowy Sącz, PL218
33650000 General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents —
11 Część nr 11: Natalizumab
Nowy Sącz, PL218
33650000 General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents —
12 Część nr 12: Okrelizumab
Nowy Sącz, PL218
33650000 General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents —
13 Część nr 13: Kladrybina
Nowy Sącz, PL218
33650000 General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents —
14 Część nr 14: Alemtuzumabum
Nowy Sącz, PL218
33650000 General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents —
15 Część nr 15: Interferon β- 1a
Nowy Sącz, PL218
33650000 General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents —
16 Część nr 16: Interferon β- 1b
Nowy Sącz, PL218
33650000 General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents —
17 Część nr 17: Ublituksymab
Nowy Sącz, PL218
33650000 General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents —
18 Część nr 18: Immunoglobuliny
Nowy Sącz, PL218
33650000 General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents —
19 Część nr 19: Kaplacyzumab
Nowy Sącz, PL218
33650000 General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents —
20 Część nr 20: Natalizumab
Nowy Sącz, PL218
33650000 General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents —

Award criteria

TypeCriterionWeight
Pricecena—

Modifications

  • części nr 20- Natalizumab zostaje wykreślona z ogłoszenia, zmienia się wartość szacunkowa zamówienia na 4907467,30 PLN

Official publications

MediumReferenceDate
TED 764929-2025 18 November 2025
OJS 222/2025 18 November 2025

Other tenders from Szpital Specjalistyczny im. Jędrzeja Śniadeckiego

Previous and next from Szpital Specjalistyczny im. Jędrzeja Śniadeckiego

Similar open tenders

Frequently asked questions

What is the deadline to bid for this tender?
The submission deadline is 12 December 2025, 08:00. Check the official source, as dates can be modified.
What is the estimated value of this tender?
The estimated value published by the buyer is 5,094,706 zł.
Who is the buyer of this tender?
The contracting authority is Szpital Specjalistyczny im. Jędrzeja Śniadeckiego (European Union).
How can I bid for public tenders in the European Union?
Bids are submitted through the official public procurement portal in the European Union. El Vínculo helps you find tenders and analyse their documents; submission always happens at the official source.

How can I find out about similar tenders when they are published?

Create an account at el-vinculo.com and we give you a free month and set up your company's filters — contract type, CPV codes, value and territory — so you are the first to know when new tenders like this one come out in the European Union. We email you as soon as one matching your profile is published, with the whole deadline ahead to prepare the bid.

No credit card · Sign up in 2 minutes.

Get alerts for tenders like this
Create a free account and receive new public tenders published in the European Union that match your business, every day.

Start for free

Data collected from official public procurement sources. Amounts as published by the buyer.